Currently holds positions in Revance Therapeutics Inc, SI-BONE Inc, ZELTIQ Aesthetics Inc and Revance Therapeutics Inc
Position | Company | Period |
---|---|---|
Independent Director | Revance Therapeutics Inc | Sept. 5, 2017 - |
Independent Director | SI-BONE Inc | June 17, 2019 - |
President, Chief Executive Officer | ZELTIQ Aesthetics Inc | April 28, 2017 - |
President, Chief Executive Officer, Director | Revance Therapeutics Inc | Oct. 13, 2019 - |
Independent Director | Revance Therapeutics Inc | Sept. 5, 2017 - Oct. 13, 2019 |
Chairman of the Board, President, Chief Executive Officer | ZELTIQ Aesthetics Inc | Jan. 1, 2015 - April 28, 2017 |
President, Chief Executive Officer, Director | ZELTIQ Aesthetics Inc | Nov. 19, 2012 - Jan. 1, 2015 |
President, Chief Executive Officer, Interim Chief Financial Officer, Director | ZELTIQ Aesthetics Inc | Aug. 23, 2012 - Nov. 19, 2012 |
Interim President, Chief Executive Officer, Interim Chief Financial Officer, Director | ZELTIQ Aesthetics Inc | Aug. 9, 2012 - Aug. 23, 2012 |
Interim President and Chief Executive Officer, Director | ZELTIQ Aesthetics Inc | April 19, 2012 - Aug. 9, 2012 |
Director | ZELTIQ Aesthetics Inc | May 1, 2010 - April 19, 2012 |
Search
Notification date | Transaction date | B/S Transaction type |
Nb. shares Price Value |
Number of shares | Price | Total value | Details | |
---|---|---|---|---|---|---|---|---|
2024-03-08 | 2024-03-06 |
Revance Therapeutics Inc
(RVNC)
|
B Purchase |
30,000
+3.0%
6.98209,400 USD |
30,000 +3.0% | 6.98 | 209,400 USD | |
2024-02-26 | 2024-02-23 |
Glaukos Corp
(GKOS)
|
S Sale |
4,560
-12.1%
92.87423,487 USD |
4,560 -12.1% | 92.87 | 423,487 USD | |
2023-08-04 | 2023-08-03 |
Revance Therapeutics Inc
(RVNC)
|
PS Planned sale |
26,279
-3.0%
22.57593,151 USD |
26,279 -3.0% | 22.57 | 593,151 USD | |
2023-07-05 | 2023-07-03 |
Revance Therapeutics Inc
(RVNC)
|
PS Planned sale |
26,279
-2.9%
24.94655,333 USD |
26,279 -2.9% | 24.94 | 655,333 USD | |
2023-06-13 | 2023-06-09 |
Revance Therapeutics Inc
(RVNC)
|
PS Planned sale |
31,279
-3.4%
30.72960,928 USD |
31,279 -3.4% | 30.72 | 960,928 USD | |
2023-05-16 | 2023-05-15 |
Revance Therapeutics Inc
(RVNC)
|
S Sale |
70,447
-7.1%
34.552,433,725 USD |
70,447 -7.1% | 34.55 | 2,433,725 USD | |
2021-11-29 | 2021-11-29 |
Revance Therapeutics Inc
(RVNC)
|
B Purchase |
40,000
+56.4%
12.90515,924 USD |
40,000 +56.4% | 12.90 | 515,924 USD | |
2016-03-23 | 2016-03-22 |
ZELTIQ Aesthetics Inc
(ZLTQ)
|
PS Planned sale |
9,698
-2.6%
25.01242,568 USD |
9,698 -2.6% | 25.01 | 242,568 USD | |
2016-03-22 | 2016-03-18 |
ZELTIQ Aesthetics Inc
(ZLTQ)
|
PS Planned sale |
1,272
-0.3%
25.0131,816 USD |
1,272 -0.3% | 25.01 | 31,816 USD |